Clinical study of Solifenacin and Imidafenacin in OAB patients with nocturia
- Conditions
- Overactive bladder
- Registration Number
- JPRN-UMIN000009137
- Lead Sponsor
- Clinical Research Support Center Kyushu
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Not provided
1) Patients who have administered prohibited substances or done prohibited therapy within the 4weeks before enrollment 2) Patients who started restricted substances and changed usage or dosage of restricted substances for determined period before enrollment 3) Patients with prostate cancer, neurogenic bladder, urethral stricture, chronic bacterial prostatitis, urinary tract infection, urinary tract stones and interstitial cystitis 4) Patients with urinary retention 5) Patients with obstruction of pylorus, duodenum and gut and patients with paralytic ileus 6) Patients with decrease of enterokinesis and gastrointestinal tract tension 7) Patients with closure-angle glaucoma 8) Patients with myasthenia gravis 9) Patients with serious liver dysfunction, kidney dysfunction and heart disease. 10) Hypersensitivity to anti-cholinergic agents. 11) Residual urine volume is more than 100mL 12) Patients with polyuria 13) Any other patients who are regarded as unsuitable for this study by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method sefulness for nocturia
- Secondary Outcome Measures
Name Time Method